Here are some competitors in the c diff space.... some could see this as positive because the mechanisms are different and highlights need for prevention and treatment.... some will see this as another company already having approval where IMC are still in early trials.....
https://www.biopharmadive.com/news/fda-rebiotix-microbiome-c-diff-advisers-committee-vote/632489/
Here are some competitors in the c diff space.... some could see...
Add to My Watchlist
What is My Watchlist?
